Biolumic develops ultraviolet light systems that change the way plants grow by activating certain plant responses that open cellular pathways – resulting in increased disease resistance, yield and crop uniformity.  Biolumic’s ultraviolet light systems significantly increase yields of transplanted crops (nursery to field) by up to 41%. 

Biolumic first engaged with Enterprise Angels back in 2014 and has seen good support from investors in subsequent capital raises as the company has grown.
In February 2021 NZGCP interviewed Dr Jason Wargent Biolumic founder and Chief Science Officer as part of their Kōrerorero series. Read the conversation here.